Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22751
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPaz-Ares, L-
dc.contributor.authorDoebele, R C-
dc.contributor.authorFarago, A F-
dc.contributor.authorLiu, S V-
dc.contributor.authorChawla, S P-
dc.contributor.authorTosi, D-
dc.contributor.authorBlakely, C M-
dc.contributor.authorKrauss, J C-
dc.contributor.authorSigal, D-
dc.contributor.authorBazhenova, L-
dc.contributor.authorJohn, Thomas-
dc.contributor.authorBesse, B-
dc.contributor.authorWolf, J-
dc.contributor.authorSeto, T-
dc.contributor.authorChow-Maneval, E-
dc.contributor.authorYe, C-
dc.contributor.authorSimmons, B-
dc.contributor.authorDemetri, G D-
dc.date.accessioned2020-03-10T22:06:20Z-
dc.date.available2020-03-10T22:06:20Z-
dc.date.issued2019-04-
dc.identifier.citationAnnals of oncology : official journal of the European Society for Medical Oncology 2019; 30 Suppl 2: ii48-ii49-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/22751-
dc.language.isoeng-
dc.titleEntrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001.-
dc.typeJournal Article-
dc.identifier.journaltitleAnnals of oncology : official journal of the European Society for Medical Oncology-
dc.identifier.affiliationHospital 12 de Octubre, Madrid, Spain-
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medical Oncology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationUniversity of Colorado, Aurora, CO, USA-
dc.identifier.affiliationMassachusetts General Hospital, Boston, MA, USA-
dc.identifier.affiliationGeorgetown University, Washington, DC, USA-
dc.identifier.affiliationSarcoma Oncology Research Center, Santa Monica, CA, USA-
dc.identifier.affiliationMedical Oncology Departement, Institut du Cancer de Montpellier Inserm U1194, Montpellier University, Montpellier, France-
dc.identifier.affiliationUniversity of California, San Francisco, CA, USA-
dc.identifier.affiliationUniversity of Michigan, Ann Arbor, MI, USA-
dc.identifier.affiliationScripps Clinic, La Jolla, CA, USA-
dc.identifier.affiliationUniversity of California, San Diego, CA, USA-
dc.identifier.affiliationGustave Roussy Cancer Campus, Villejuif, France-
dc.identifier.affiliationUniversity Hospital of Cologne, Cologne, Germany-
dc.identifier.affiliationNational Kyushu Cancer Center, Fukuoka, Japan-
dc.identifier.affiliationIgnyta, Inc., San Diego, CA, USA-
dc.identifier.affiliationGenentech, South San Francisco, CA, USA-
dc.identifier.affiliationDana-Farber Cancer Institute, Boston, MA, USA-
dc.identifier.doi10.1093/annonc/mdz063.011-
dc.identifier.pubmedid32131246-
dc.type.austinJournal Article-
local.name.researcherJohn, Thomas
item.languageiso639-1en-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptMedical Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

10
checked on Nov 5, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.